Changing comorbidity classification patterns at radical prostatectomy during a 10-year period

Urologic Oncology: Seminars and Original Investigations

Volumn 25, Issue 1, 2007, Pages 26-31

  Froehner, Michael ^a   Garbrecht, Bernd ^a   Hakenberg, Oliver W ^a   Koch, Rainer ^a   Litz, Rainer J ^a   Oehlschlaeger, Sven ^a   Twelker, Lars ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Age; American Society of Anesthesiologists classification; Charlson score; Comorbidity; Heart disease; Preoperative cardiopulmonary risk assessment; Prostate cancer; Radical prostatectomy; Shift; Stage

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SURGERY; COMORBIDITY; DIABETES MELLITUS; DISEASE CLASSIFICATION; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TREND STUDY;

AGED; COMORBIDITY; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 33845902780     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2006.02.004     Document Type: Article

References (24)

1. Barry M.J., Albertsen P.C., Bagshaw M.A., et al. Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: A retrospective analysis. Cancer 91 (2001) 2302-2314
2. Sweat S.D., Bergstralh E.J., Slezak J., et al. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol 168 (2002) 525-529
3. Froehner M., Koch R., Litz R.J., et al. Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy. Scand J Urol Nephrol 39 (2005) 449-454
4. Derweesh I.H., Kupelian P.A., Zippe C., et al. Continuing trends in pathological stage migration in radical prostatectomy specimens. Urol Oncol 22 (2004) 300-306
5. Winkler M.H., Khan F.A., Hoh I.M., et al. Time trends in case selection, stage and prostate-specific antigen recurrence after radical prostatectomy: A multicentre audit. BJU Int 93 (2004) 725-729
6. Han M., Partin A.W., Chan D.Y., et al. An evaluation of the decreasing incidence of positive surgical margins in a large retropubic prostatectomy series. J Urol 171 (2004) 23-26
7. Bott S.R., Freeman A.A., Stenning S., et al. Radical prostatectomy: Pathology findings in 1001 cases compared with other major series and over time. BJU Int 95 (2005) 34-39
8. Moul J.W., Wu H., Sun L., et al. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: An overview of the Department of Defense Center for Prostate Disease Research national database. Surgery 132 (2002) 213-219
9. Evans H.S., and Moller H. Recent trends in prostate cancer incidence and mortality in southeast England. Eur Urol 43 (2003) 337-341
10. Froehner M., Koch R., Litz R.J., et al. Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy. Eur Urol 47 (2005) 190-195
11. ASA Physical Status Classification System. Available at: http://www.frca.co.uk/article.aspx?articleid=100184. Accessed April 1, 2006.
12. Cardiovascular disease classification chart. Available at: http://www.cochranfoundation.com/docs/nyha-class.htm. Accessed April 1, 2006.
13. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 40 (1987) 373-383
14. Froehner M., Koch R., and Litz R. Which conditions contributing to the Charlson score predict survival after radical prostatectomy?. J Urol 171 (2004) 697-699
15. Singh R., and O'Brien T.S. Comorbidity assessment in localized prostate cancer: A review of currently available techniques. Eur Urol 46 (2004) 28-41
16. Hall W.H., Jani A.B., Ryu J.K., et al. The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer. Prostate Cancer Prostatic Dis 8 (2005) 22-30
17. Junger A., Engel J., Quinzio L., et al. Risikoindizes, Scoring-Systeme und prognostische Modelle in der Anästhesie und Intensivmedizin. Teil I: Anästhesie. Anästhesiol Intensivmed Notfallmed Schmerzther 37 (2002) 520-527
18. Dillioglugil Ö., Leibman B.D., and Leibman N.S. Risk factors for complications and morbidity after radical retropubic prostatectomy. J Urol 157 (1997) 1760-1767
19. Froehner M., Litz R., Manseck A., et al. Relationship of comorbidity, age and perioperative complications in patients undergoing radical prostatectomy. Urol Int 7 (2001) 283-288
20. Matin S.F., Abreu S., Ramani A., et al. Evaluation of age and comorbidity as risk factors after laparoscopic urologic surgery. J Urol 170 (2003) 1115-1120
21. Reid B.C., Alberg A.J., Klassen A.C., et al. The American Society of Anesthesiologists' class as a comorbidity index in a cohort of head and neck cancer surgical patients. Head Neck 23 (2001) 985-994
22. van den Broek G.B., Rasch C.R.N., Pameijer F.A., et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 101 (2004) 1809-1817
23. Fischer H, Kück U. Bevölkerungsentwicklung und Migration von 1999 bis 2002: Berlin und die neuen Bundesländer im Vergleich. In: Statistisches landesamt Berlin (ed). Statistische Monatsschrift, 58. Jahrgang, Nr. 11/2004, Druckerei Schlesener KG, Berlin (Germany).
24. Albertsen P.C., Hanley J.A., Barrows G.H., et al. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 97 (2005) 1248-1253